Pete Kaufman joined Panish, Shea & Boyle LLP in 2010. Mr. Kaufman specializes in mass tort pharmaceutical and medical device litigation. Since 2001, he has tried cases in nearly every major pharmaceutical litigation, including Accutane, Vioxx, phenylpropanolamine (PPA), fen-phen/diet drugs and Adderall. During that time, Mr. Kaufman received verdicts in excess of $35 million and settlements of nearly $100 million.
He has played a central role in a number of national pharmaceutical litigations. Mr. Kaufman currently serves as the co-chair of the Trial Package committee for the Vioxx Multi-District Litigation (MDL), which resulted in a $4.7 billion national settlement. He also served on the Discovery and Science committees in the Vioxx litigation and has tried Vioxx cases in New Jersey, Louisiana, Florida and California. In the Bextra/Celebrex litigation, he was a member of the MDL Plaintiff’s Steering Committee and resolved hundreds of cases involving plaintiffs who suffered heart attacks and strokes.
In the coordinated Baycol litigation, in state court in Philadelphia, Pennsylvania, Mr. Kaufman served on the discovery and deposition committees, worked with leading medical experts on a major national class action case, and settled nearly 100 individual cases. Mr. Kaufman has also resolved claims related to Stevens-Johnson Syndrome, the drugs Rezulin and Ketek, for liver-related injuries, Accutane, and numerous other personal injury cases.
Recently, Mr. Kaufman handled one of the first cases in the country against a generic drug manufacturer, in which the court held, in a precedential decision, that generic manufacturers of drugs have the same liability as brand-name manufacturers, Munroe v. Barr Laboratories Inc., 2009 WL 4047949 (N.D.Fla., 2009).
Regrettably, in their recent decision in Pliva, Inc., et al v. Mensing, 564 U. S. 1 (2011), the Supreme Court of the United States reversed a similar decision, and leaving the millions and millions of Americans who take generics drugs every day without any remedy if they are harmed by these products.
Currently, Mr. Kaufman’s practice is focused primarily on medical device litigation, including cases involving the recently recalled DePuy ASR hip implant system and Kugel hernia mesh.
Rate : $$$